Read the post

Signia Therapeutics to present at the 2nd i4iD – Immunotherapies for infectious Diseases – conference

November 21, 2018

Signia Therapeutics announces it has been selected to present its strategy based on clinical gene expression infection signatures to the upcoming 2nd edition of i4iD “Immunotherapies for Infectious Diseases – host-directed therapies”.

This conference is organized jointly by MabDesign, a French non-profit membership organization in the immunotherapy field, and BIOASTER, a technology institute that leads research programs in four major application fields in health-related microbiology and infectious diseases. The conference will take place in MATMUT Stadium, Lyon, France on December 10thand 11th, 2018.

Presentation will be delivered by Dr Philippe Personne, CEO of Signia Therapeutics, on Monday December 10thin the pitch session “Innovation on HDT Approaches To Treat Infectious Diseases”.

Visit the i4id website https://i4id.org/and Signia Therapeutics website https://signiatherapeutics.com/fr/for detailed information.

Share it

Leave a comment

Contact us

Do not hesitate to contact us!

Location
L’Atrium – 43 boulevard du 11 novembre 1918 69100 Villeurbanne, France
Phone
(+33) 478771037
Email
contact@signiatherapeutics.com
Leave a comment

Signia therapeutics.com - Copyright 2018. All right reserved.